Taiho Pharmaceutical Co Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group develops and markets pharmaceutical products in the field of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical products such as anti-allergic agents, anti-tumor agents, H2 receptor antagonists, antibiotics and medical devices; and consumer health products such as vitamin tonic, herbal digestive medicine, topical analgesics, antifungal cream, herbal medicine powder, and others. Taiho has production facilities in Tokushima, Saitama, Okayama, Kitajima and Inuyama. It operates through its subsidiaries in Japan, China, Singapore, the UK and the US. Taiho is headquartered in Tokyo, Japan.

Taiho Pharmaceutical Co Ltd Key Recent Developments

Jul 03,2018: Taiho Pharmaceutical Completes New Production Facility for Highly Potent Pharmaceutical Ingredients at Saitama Site
May 28,2018: Taiho Pharmaceutical to Launch Tiovita Drink Aibitasu Zero Nationwide on May 28, 2018 “No fatigue the next day!”
Feb 21,2018: Taiho Pharmaceutical Recognized as White 500 for Outstanding Health and Productivity Management
Nov 17,2017: Taiho Pharmaceutical Head Office to Temporarily Relocate
Oct 05,2017: Taiho Pharmaceutical Releases Pitas Sore Throat Troche in Japan on October 5A Sticker-type Troche to be Placed on the Roof of the Mouth That is Helpful in Business Meetings

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.